Biological Computing Startup BioMap Raises $100 Million in New Funding

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING: Apple Hopes Cheaper IPhones Will Woo Chinese Customers; Air Taxi Developer’s Listing Shows Tencent Can’t Shake Its Flying Car Dreams

LATEST: Air Taxi Developer’s Listing Shows Tencent Can’t Shake Its Flying Car Dreams; Apple Hopes Cheaper IPhones Will Woo Chinese Customers; Two Chinese Tech Stocks Sizzle on Latest Hot Concept in Virtual Reality; China Tech Stocks Stumble in Rush Back Toward Bull Market; WeRide Joins With Carmaker, Courier to Commercialize Self-Driving Delivery Vans; JD.com-Backed Dada’s Autonomous Delivery Investment Undercuts Revenue Jump; Non-Innovative Medtech Companies Are Winning Too Much Venture Capital, Official Says; Chipmaker SMIC Inks Deal With Shanghai for $8.8 Billion Factory; Tech Insider: EV Sales a Mixed Bag, MediaTek Stays on Top, Xiaomi’s New Direction; BGI’s Gene Sequencer Spin-Off Approved for Shanghai IPO; Smartphone Giant Xiaomi Officially Revs Up Smart Car Business; China’s GPS Alternative Gets Regulatory Roadmap in Push to Boost Adoption; Meituan Faces Fresh Regulatory Trouble Over Mobike Acquisition; China Hammers Mobile Gaming Industry With Tough New Limits; ByteDance Acquires China’s Largest Virtual Reality Headset Maker; Microchip Design Specialist Arm China Takes a Turn Into Autonomous Driving; Tech Insider: Self-Flying Hopeful EHang Runs Into Turbulence, Chipmaker Arm China Joins Auto Drive, iQiyi Gives Up on Its Idols; Self-Flying Vehicle Specialist EHang Hits Earnings Turbulence; Volvo to Buy Chinese Truck Manufacturer to Capitalize on Delivery Boom; Douyin Removes User Clips After Backing Down From Copyright Showdown With Tencent Video

By Ding Yi / Aug 02, 2021 07:29 PM / Business & Tech

BioMap, a Chinese startup that uses biological computing technology to develop drugs, has raised more than $100 million in a series A funding round led by GGV Capital.

Biological computing is a technology that operates at the intersection of biology, engineering and computer science and that uses cells or their sub-component molecules such as DNA to perform functions traditionally performed by an electronic computer.

The round also attracted investors including Baidu, Legend Capital, Bluerun Ventures and Xianghe Capital, BioMap said in a statement on Saturday.

The Beijing-based company said that it will use the fresh capital to boost R&D of its biocomputing technology.

Co-founded by Baidu CEO Robin Li and former Baidu Ventures’ CEO Wei Liu last year, BioMap said that it will focus on developing therapies and medicines for tumors, autoimmune diseases and fibrotic diseases.

Contact reporter Ding Yi (yiding@caixin.com) and editor Heather Mowbray (heathermowbray@caixin.com)

Share this article

Open WeChat and scan the QR code